Accurate Wealth Management 13F: Cuts MCK Stake by $1.1M

Accurate Wealth Management lowered its investment in McKesson Corporation (NYSE:MCK) during the quarter, dropping 1,142 shares to wrap up the period with 744 shares. The firm shared the details in a Form 13F filing with the Securities and Exchange Commission on October 20, 2026. The remaining shares held an estimated value of $715,312 at the time of the report.

MCK McKesson Corporation

$1,030.12 ▲ +25.48% year to date

1M 3M YTD

Daily close · Oct 20, 2026

What Changed in Accurate Wealth Management's McKesson Position

The fund held 1,886 shares of the medical distributor before the latest adjustment. Dropping 1,142 shares worked out to a 60.5% reduction in its overall stake. The filing reflects portfolio adjustments made during the quarter, bringing the fund's total holding down to 744 shares.

Other Institutional Activity in McKesson

James Hambro & Partners grew its holdings by 4,301 shares, ending with 138,952 shares worth about $118,760,191. Lone Pine Capital held 392,224 shares valued at roughly $296,364,445. Brandes Investment Partners reduced its stake by 15,878 shares, or 8.4%, leaving 172,487 shares worth about $130,331,173. Franklin Resources, Inc. trimmed its position by 158,060 shares, dropping 5.2% to hold 2,905,114 shares valued at $2,992,616,019. Massachusetts Financial Services Co. cut its holdings by 453,894 shares, or 15.7%, ending with 2,446,386 shares worth $2,520,071,134.

McKesson Corporation Stock Up 2.5%

McKesson shares closed at $1,030.12 on October 20, 2026. The stock recently traded around that same level, sitting well above its 50-day moving average of $899.25 and its 200-day moving average of $854.92. The company commands a market capitalization near $117.8 billion.

Recent Earnings

McKesson reported strong financial results across its operations, generating $410.98 billion in revenue over the trailing twelve months with a net profit margin of 1.1%. Earnings per share over the same period reached $37.31. The company is scheduled to report its next round of financial results on November 4, 2026.

Dividend

The company pays an annual dividend rate of $3.76 per share, which translates to a dividend yield of 0.37%. The payout accounts for 8.8% of the company's earnings.

Insider Buying and Selling at McKesson Corporation

Chief Executive Officer Brian Scott Tyler sold 8,463 shares on July 7, 2026, at an average price of $793.56 for a total value of $6,715,898. Director Bradley E Lerman sold 301 shares on August 10, 2026, at $892.32 per share, totaling $268,590. Officer Napoleon B Rutledge Jr disposed of 111 shares on September 8, 2026, at $891.45 per share, worth $98,951. EVP, CIO and CTO Francisco Fraga sold 800.491 shares on October 15, 2026, at $995.80 per share for a total of $797,128.94 under a pre-arranged trading plan.

Analysts Set New Price Targets

On August 19, 2026, Barclays maintained its Overweight rating and raised its price target to $1000.00 from $925.00. RBC Capital reiterated a Sector Perform rating with an 845.00 price target on September 14, 2026. Leerink Partners maintained an Outperform rating on October 7, 2026, lifting its target from $1030.00 to $1070.00. UBS kept a Buy rating on October 16, 2026, and raised its target from $1080.00 to $1200.00. Mizuho maintained a Neutral rating on October 20, 2026, while boosting its target to $1020.00 from $905.00. Overall, the stock carries a consensus buy recommendation from 14 analysts, with a mean price target of $1,001.43.

About McKesson

McKesson Corporation operates as a healthcare services company based in Irving, Texas, distributing pharmaceuticals and medical supplies while building healthcare technology solutions. The enterprise supports the medical sector through four primary divisions, supplying hospitals, pharmacies, and specialty care providers across the country.

Bottom Line

Investors are keeping an eye on the company's upcoming earnings release on November 4, 2026, for further updates on operational growth. Institutional ownership shifts will continue to surface through subsequent SEC disclosures.